BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9644298)

  • 21. Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients.
    Cruciani M; Malena M; Bosco O; Nardi S; Serpelloni G; Mengoli C
    J Clin Oncol; 2003 Nov; 21(22):4127-37. PubMed ID: 14615441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolone prophylaxis for bacterial infections in neutropenic patients with hematologic malignancies.
    Nenova IS; Ananostev NH; Goranov SE; Mateva NG; Haidushka IA
    Folia Med (Plovdiv); 2001; 43(4):40-5. PubMed ID: 12087953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P; Baumgartner JD; Glauser MP; Cometta A
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.
    Wojenski DJ; Barreto JN; Wolf RC; Tosh PK
    Clin Ther; 2014 Jun; 36(6):976-81. PubMed ID: 24832560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.
    Del Favero A; Menichetti F
    Eur J Cancer; 1993; 29A Suppl 1():S2-6. PubMed ID: 8427721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].
    Guy H; Caillot D; Solary E; Bielefeld P; Portier H; Kazmierczak A
    Presse Med; 1987 Dec; 16(43):2172-5. PubMed ID: 2963306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients.
    Rutschmann OT; Zwahlen A
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):441-4. PubMed ID: 7556234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.
    Muñoz L; Martino R; Subirà M; Brunet S; Sureda A; Sierra J
    Leuk Lymphoma; 1999 Aug; 34(5-6):585-9. PubMed ID: 10492083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
    Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A;
    N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.
    Carratala J; Fernandez-Sevilla A; Tubau F; Dominguez MA; Gudiol F
    Antimicrob Agents Chemother; 1996 Feb; 40(2):503-5. PubMed ID: 8834911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones].
    Sinkó J; Cser V; Konkoly Thege M; Masszi T
    Orv Hetil; 2011 Jul; 152(27):1063-7. PubMed ID: 21676672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of fluoroquinolones as prophylactic agents in patients with neutropenia.
    Patrick CC
    Pediatr Infect Dis J; 1997 Jan; 16(1):135-9; discussion 160-2. PubMed ID: 9002124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences.
    Aparicio JR; Such J; Pascual S; Arroyo A; Plazas J; Girona E; Gutiérrez A; de Vera F; Palazón JM; Carnicer F; Pérez-Mateo M
    J Hepatol; 1999 Aug; 31(2):277-83. PubMed ID: 10453941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and microbiological effects of biapenem in febrile neutropenic patients with hematologic malignancies.
    Isobe Y; Kanemitsu N; Yahata Y; Masuda A; Tsukune Y; Sugimoto K
    Scand J Infect Dis; 2009; 41(3):237-9. PubMed ID: 19116887
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.
    Chen CY; Tsay W; Tang JL; Tien HF; Chen YC; Chang SC; Hsueh PR
    Epidemiol Infect; 2010 Jul; 138(7):1044-51. PubMed ID: 19941686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.
    Ryu BH; Lee SC; Kim M; Eom Y; Jung J; Kim MJ; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):937-943. PubMed ID: 31925572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.